"Any future switch would come down to how well your current treatment is working for you, how well you tolerate it, and whether a different format genuinely makes it easier to stay on track long term, rather than preference alone. Aniyah Mansuri , weight loss expert at myBMI Sources Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial (2025)
Vomiting, which is uncommon at lower doses, begins to affect approximately 10 percent of users
Low blood sugar can occur and is marked by signs of dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, change in eyesight, or sweating
This medication follows a gradual titration schedule to minimize side effects and allow your body the time to adapt